 |
인쇄하기
취소
|
Chong Kun Dang develop novel formulation technology for amlodipine
Chong Kun Dang Pharmaceutical Co. said it has filed a Korean patent application (No. 10-2004-0048208) related to a process of synthesizing high-purity amlodipine maleate with less impurities.
The core micro-coating formulation technology, which was independently developed by Chong Kung Dang through intensive studies, is better than Pfizer's conventional process in terms of stability, the com...
The core micro-coating formulation technology, which was independently developed by Chong Kung Dang through intensive studies, is better than Pfizer's conventional process in terms of stability, the com...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.